Literature DB >> 12808072

Chlamydial vaccine development.

David Longbottom1.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12808072     DOI： 10.1099/jmm.0.05093-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN： 0022-2615            Impact factor:   2.472


× No keyword cloud information.
  12 in total

Review 1.  Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.

Authors:  Sam Vasilevsky; Gilbert Greub; Denise Nardelli-Haefliger; David Baud
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

2.  Dendrimer-conjugated peptide vaccine enhances clearance of Chlamydia trachomatis genital infection.

Authors:  Ingrid S Ganda; Qian Zhong; Mirabela Hali; Ricardo L C Albuquerque; Francine F Padilha; Sandro R P da Rocha; Judith A Whittum-Hudson
Journal:  Int J Pharm       Date:  2017-05-22       Impact factor: 5.875

Review 3.  Chlamydia trachomatis control requires a vaccine.

Authors:  Robert C Brunham; Rino Rappuoli
Journal:  Vaccine       Date:  2013-01-29       Impact factor: 3.641

Review 4.  Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis.

Authors:  Hong Yu; Karuna P Karunakaran; Xiaozhou Jiang; Robert C Brunham
Journal:  Expert Rev Vaccines       Date:  2016-03-21       Impact factor: 5.217

Review 5.  Chlamydiaceae infections in pig.

Authors:  Katelijn Schautteet; Daisy Vanrompay
Journal:  Vet Res       Date:  2011-02-07       Impact factor: 3.683

Review 6.  Chlamydia trachomatis vaccine research through the years.

Authors:  Katelijn Schautteet; Evelien De Clercq; Daisy Vanrompay
Journal:  Infect Dis Obstet Gynecol       Date:  2011-06-26

7.  Vibrio cholerae ghosts (VCG) exert immunomodulatory effect on dendritic cells for enhanced antigen presentation and induction of protective immunity.

Authors:  Francis O Eko; Jayanti Mania-Pramanik; Roshan Pais; Qing Pan; Daniel M N Okenu; Arieian Johnson; Chris Ibegbu; Cheng He; Qing He; Raedeen Russell; Carolyn M Black; Joseph U Igietseme
Journal:  BMC Immunol       Date:  2014-12-31       Impact factor: 3.615

8.  Novel Chlamydia pneumoniae vaccine candidates confirmed by Th1-enhanced genetic immunization.

Authors:  Yihang Li; Sudhir K Ahluwalia; Alexandre Borovkov; Andrey Loskutov; Chengming Wang; Dongya Gao; Anil Poudel; Kathryn F Sykes; Bernhard Kaltenboeck
Journal:  Vaccine       Date:  2009-12-02       Impact factor: 3.641

9.  Escherichia coli Nissle 1917 bacterial ghosts retain crucial surface properties and express chlamydial antigen: an imaging study of a delivery system for the ocular surface.

Authors:  Jacqueline Montanaro; Aleksandra Inic-Kanada; Angela Ladurner; Elisabeth Stein; Sandra Belij; Nora Bintner; Simone Schlacher; Nadine Schuerer; Ulrike Beate Mayr; Werner Lubitz; Nikolaus Leisch; Talin Barisani-Asenbauer
Journal:  Drug Des Devel Ther       Date:  2015-07-21       Impact factor: 4.162

10.  Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection.

Authors:  Pengfei Jiang; Wangqi Du; Yirong Xiong; Yan Lv; Juan Feng; Shanli Zhu; Xiangyang Xue; Shao Chen; Lifang Zhang
Journal:  Oncotarget       Date:  2015-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.